Lasa Supergeneri

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE670X01014
  • NSEID: LASA
  • BSEID: 540702
INR
7.69
-0.15 (-1.91%)
BSENSE

Aug 11, 03:30 PM

BSE+NSE Vol: 31.06 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 1002834,
    "name": "Lasa Supergeneri",
    "stock_name": "Lasa Supergeneri",
    "full_name": "Lasa Supergenerics Ltd",
    "name_url": "stocks-analysis/lasa-supergeneri",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "7.69",
    "chg": -0.15,
    "chgp": "-1.91%",
    "dir": -1,
    "prev_price": "7.84",
    "mcapval": "40.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 540702,
    "symbol": "LASA",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "sector_id": 65,
    "indexname": "India SENSEX",
    "isin": "INE670X01014",
    "curr_date": "Aug 11, 03:30 PM",
    "curr_time": "23:57 PM",
    "last_traded_at": "Aug 11, 03:30 PM IST",
    "bse_nse_vol": "31.06 k",
    "exc_status": "Active",
    "traded_date": "Aug 11, 2026",
    "traded_date_str": "2026 08 11",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/lasa-supergeneri-1002834-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Lasa Supergenerics Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/lasa-supergenerics-ltd-is-rated-strong-sell-4139663",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/LasaSupergeneri_mojoScore_4139663.png",
        "date": "2026-08-06 10:10:42",
        "description": "Lasa Supergenerics Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 11 February 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 06 August 2026, providing investors with an up-to-date view of its fundamentals, returns, and overall outlook."
      },
      {
        "title": "When is the next results date for Lasa Supergenerics Ltd?",
        "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-lasa-supergenerics-ltd-4138797",
        "imagepath": "",
        "date": "2026-08-05 23:20:09",
        "description": "Lasa Supergenerics Ltd is scheduled to declare its results on 14 August 2026...."
      },
      {
        "title": "Lasa Supergenerics Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/lasa-supergenerics-ltd-is-rated-strong-sell-4117645",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/LasaSupergeneri_mojoScore_4117645.png",
        "date": "2026-07-23 10:10:26",
        "description": "Lasa Supergenerics Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 11 February 2025. However, the analysis below reflects the stock’s current position as of 23 July 2026, incorporating the latest fundamentals, returns, and financial metrics to provide investors with an up-to-date perspective."
      },
      {
        "title": "Lasa Supergenerics Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/lasa-supergenerics-ltd-is-rated-strong-sell-4084745",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/LasaSupergeneri_mojoScore_4084745.png",
        "date": "2026-07-02 10:10:53",
        "description": "Lasa Supergenerics Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 11 Feb 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 02 July 2026, providing investors with an up-to-date view of the stock’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Lasa Supergenerics Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/lasa-supergenerics-ltd-is-rated-strong-sell-4061053",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/LasaSupergeneri_mojoScore_4061053.png",
        "date": "2026-06-18 10:10:34",
        "description": "Lasa Supergenerics Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 11 February 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 18 June 2026, providing investors with an up-to-date perspective on the stock’s fundamentals, valuation, financial trend, and technical outlook."
      },
      {
        "title": "Lasa Supergenerics Ltd Locks at Lower Circuit With 3.7% Loss — Sellers Queue, No Buyers in Sight",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/lasa-supergenerics-ltd-hits-lower-circuit-amid-heavy-selling-pressure-4026543",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/LasaSupergeneri_stocks_hitting_lower_circuit_4026543.png",
        "date": "2026-06-01 12:00:12",
        "description": "At Rs 7.90, sellers were still queuing — but there were no buyers willing to take the other side. Lasa Supergenerics Ltd locked at its lower circuit of 5% on 1 Jun 2026, with unfilled sell orders and a frozen price."
      },
      {
        "title": "Lasa Supergenerics Q4 FY26: Revenue Collapse Signals Critical Operational Crisis",
        "link": "https://www.marketsmojo.com/news/result-analysis/lasa-supergenerics-q4-fy26-revenue-collapse-signals-critical-operational-crisis-4024686",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/LasaSupergeneri_quaterlyResult_4024686.png",
        "date": "2026-05-30 23:54:15",
        "description": "Lasa Supergenerics Ltd., a micro-cap pharmaceutical manufacturer with a market capitalisation of ₹42.00 crores, reported catastrophic fourth-quarter results for FY26, with the company posting negative net sales of ₹0.13 crores and a net loss of ₹4.16 crores. The stock, trading at ₹8.30 as of May 29, 2026, has plummeted 42.24% over the past year and now trades 50% below its 52-week high of ₹16.60, reflecting investor exodus from what appears to be a company in severe operational distress."
      },
      {
        "title": "Lasa Supergenerics Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/lasa-supergenerics-ltd-is-rated-strong-sell-4013473",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/LasaSupergeneri_mojoScore_4013473.png",
        "date": "2026-05-26 10:10:29",
        "description": "Lasa Supergenerics Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 11 Feb 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 26 May 2026, providing investors with an up-to-date view of its fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Upper Circuit at Rs 8.38: Is Lasa Supergenerics Ltd’s 5% Surge Driven by Conviction or Thin Liquidity?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/lasa-supergenerics-ltd-surges-to-upper-circuit-amid-strong-buying-pressure-4010734",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/LasaSupergeneri_stocks_hitting_upper_circuit_4010734.png",
        "date": "2026-05-25 11:00:55",
        "description": "At Rs 8.38, the buying was done — not because demand dried up, but because the exchange wouldn't allow the stock to rise further. Lasa Supergenerics Ltd locked at its upper circuit of 5% on 25 May 2026, with buyers queuing and no sellers willing to part with shares."
      }
    ],
    "total": 263,
    "sid": "1002834",
    "stock_news_url": "https://www.marketsmojo.com/news/lasa-supergenerics-1002834"
  },
  "announcements": [
    {
      "caption": "Board Meeting Intimation for The Quarter Ended June 302026",
      "datetime": "04-Aug-2026",
      "details": "Lasa Supergenerics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 inter alia to consider and approve Pursuant to Regulation 29 of the Securities and Exchange Board of the India (Listing Obligation and Disclosure Requirement) Regulation 2015 notice is hereby given that Meeting of the Board of Directors of the Company is scheduled to be held on Friday August 14 2026 inter alia; 1. To consider approve and take on records Unaudited financial results of the Company for the quarter ended June 30 2026. 2. To discuss any other matter with the permission of the Chairperson.",
      "source": "BSE"
    },
    {
      "caption": "Closure of Trading Window",
      "datetime": "29-Jun-2026",
      "details": "Closure of trading window for the quarter ended June 30 2026",
      "source": "BSE"
    },
    {
      "caption": "Compliances-Reg.24(A)-Annual Secretarial Compliance",
      "datetime": "30-May-2026",
      "details": "Annual Secretarial Compliance Report as on March 31st 2026",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "",
      "data": [
        {
          "title": "BOARD MEETING",
          "txt": "14 Aug 2026"
        }
      ]
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Lasa Supergenerics Ltd has declared <strong>2%</strong> dividend, ex-date: 16 Sep 22",
          "dt": "2022-09-16",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock newsNews and Views
stock-recommendationAnnouncement

Board Meeting Intimation for The Quarter Ended June 302026

04-Aug-2026 | Source : BSE

Lasa Supergenerics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 inter alia to consider and approve Pursuant to Regulation 29 of the Securities and Exchange Board of the India (Listing Obligation and Disclosure Requirement) Regulation 2015 notice is hereby given that Meeting of the Board of Directors of the Company is scheduled to be held on Friday August 14 2026 inter alia; 1. To consider approve and take on records Unaudited financial results of the Company for the quarter ended June 30 2026. 2. To discuss any other matter with the permission of the Chairperson.

Closure of Trading Window

29-Jun-2026 | Source : BSE

Closure of trading window for the quarter ended June 30 2026

Compliances-Reg.24(A)-Annual Secretarial Compliance

30-May-2026 | Source : BSE

Annual Secretarial Compliance Report as on March 31st 2026

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

14 Aug 2026

stock-summary
DIVIDEND

Lasa Supergenerics Ltd has declared 2% dividend, ex-date: 16 Sep 22

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available